Abiopharma

News list

Director LIPPERT JASON 🟢 acquired 1.2K shares (1 derivative) of Quanex Building Products CORP (NX) Transaction Date: Aug 27, 2026 | Filing ID: 000045

Full text

News bot Aug. 31, 2026, 9:45 p.m.
🔍 LIPPERT JASON (Director)

Company: Quanex Building Products CORP (NX)

Report Date: 2026-08-27
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 1,207
Detailed Transactions and Holdings:
- Acquired 1,207 shares of Phantom Stock Units (Derivative)
  Date: 2026-08-27 | Code: A | equity_swap_involved: 0 | shares_owned_after: 20,528.52 | transaction_form_type: 4 | Footnotes: F1, F2, F1, F1, F3
Footnotes:
- F1: Each Phantom Stock Unit is the economic equivalent of one share of common stock. Distributions under the Deferred Compensation Plan are made in cash beginning on a specified date selected by the participant or upon the participant's death, disability, or termination of service as a director.
- F2: Units credited to the participant's account under the Deferred Compensation Plan as a result of deferral of Director Compensation.
- F3: Includes 82.66 phantom stock units credited to the participant's account as a result of automatic dividend reinvestment.